Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CRMD

CorMedix (CRMD) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $7.38 +0.8% on the day -32.9% over 12 months 52-week range $6.25 – $12.73

Share price and insider trades

CRMD closeInsider buyInsider sale
68101214NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $68,800 on 2026-01-21 · Janet DillioneSold $260,000 on 2025-12-30 · Alan W DuntonSold $261,586 on 2025-11-24 · Janet DillioneBought $275,500 on 2025-10-23 · Myron KaplanSold $342,600 on 2025-11-14 · Janet DillioneSold $360,000 on 2025-12-18 · Joseph TodiscoSold $466,570 on 2025-12-02 · Janet DillioneSold $883,200 on 2025-12-09 · Janet Dillione, Steven W Lefkowitz
Bought, 12 months$276K
Sold, 12 months$2.6M
Insiders buying1
Insiders selling4

CorMedix insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $276K and 4 sold $2.6M of CRMD stock on the open market.

CRMD insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $276K bought (1 trades)$276KQ4 2025: $2.6M sold (7 trades)Q4 2025Q1 2026: $69K sold (1 trades)Q1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0$69K1
Q4 2025$276K1$2.6M7

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit−$91KOn all tracked purchases -33.0%

Summary

Over the past 12 months, 1 CorMedix Inc. insider reported open-market purchases totaling $276K, while 4 insiders reported sales totaling $2.6M. 5 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jan 22SEC Janet DillioneDirector Sell Plan 10,00038,473 held (−21%) $6.88 $69K +7.3% —
Jan 2SEC Alan W DuntonDirector Sell Plan 20,00040,250 held (−33%) $13.00 $260K -43.2% —
Dec 19SEC Joseph TodiscoCEO Sell Plan 30,000509,496 held (−6%) $12.00 $360K -38.5% —
Dec 11SEC Janet DillioneDirector Sell Plan 34,00048,473 held (−41%) $12.00 $408K -38.5% —
Dec 10SEC Steven W LefkowitzDirector Sell 40,00080,498 held (−33%) $11.88 $475K -37.9% —
Dec 4SEC Janet DillioneDirector Sell Plan 46,65748,473 held (−49%) $10.00 $467K -26.2% —
Nov 26SEC Janet DillioneDirector Sell 26,34348,473 held (−35%) $9.93 $262K -25.7% —
Nov 18SEC Janet DillioneDirector Sell 30,00048,473 held (−38%) $11.42 $343K -35.4% —
Oct 27SEC Myron KaplanDirector Buy 25,000201,034 held (+14%) $11.02 $276K -33.0% —

Insiders at CorMedix Inc.

InsiderBoughtSoldLast filingScore
Janet DillioneDirector — $1.5M Jan 22, 2026 —
Myron KaplanDirector $276K — Oct 27, 2025 —
Steven W LefkowitzDirector — $475K Dec 10, 2025 —
Joseph TodiscoCEO — $360K Dec 19, 2025 —
Alan W DuntonDirector — $260K Jan 2, 2026 —

CRMD stock: common questions

Are CorMedix Inc. insiders buying CRMD stock?

In the past 12 months, 1 insiders reported open-market purchases of CRMD worth $276K. The latest was Director Myron Kaplan bought $276K of CRMD at $11.02 — first open-market purchase in our records.

Are CorMedix Inc. insiders selling CRMD stock?

4 insiders reported sales worth $2.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CRMD's 52-week range?

Over the past year CRMD has traded between $6.25 and $12.73. It last closed at $7.38 on Oct 9, 2026.